FDA Inspection 1256951 — Memorial Hermann Texas Medical Center
The FDA completed an inspection of Memorial Hermann Texas Medical Center on Nov 18, 2024 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 18, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)